126 related articles for article (PubMed ID: 28065323)
21. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
Chakraborty S; Dhakshinamurthy GS; Misra SK
J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
[TBL] [Abstract][Full Text] [Related]
22. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
Tay LM; Xu C
Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
[No Abstract] [Full Text] [Related]
23. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of dual-functional targeting probes for cancer theranostics based on iron oxide nanoparticles coated by centipede-like polymer connected with pH-responsive anticancer drug.
Zhao H; Li Z; Yang B; Wang J; Li Y
J Biomater Sci Polym Ed; 2015; 26(16):1178-89. PubMed ID: 26249213
[TBL] [Abstract][Full Text] [Related]
25. Activatable Theranostics.
Huang P
Curr Med Chem; 2019; 26(8):1310. PubMed ID: 31189459
[No Abstract] [Full Text] [Related]
26. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS
Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629
[TBL] [Abstract][Full Text] [Related]
27. Safe approaches for camptothecin delivery: Structural analogues and nanomedicines.
Botella P; Rivero-Buceta E
J Control Release; 2017 Feb; 247():28-54. PubMed ID: 28027948
[TBL] [Abstract][Full Text] [Related]
28. Editorial.
Hennink WE; Paulusse JM
J Control Release; 2016 Dec; 244(Pt B):137-138. PubMed ID: 27989301
[No Abstract] [Full Text] [Related]
29. Cardiovascular nanomedicine: the route ahead.
Iafisco M; Alogna A; Miragoli M; Catalucci D
Nanomedicine (Lond); 2019 Sep; 14(18):2391-2394. PubMed ID: 31456471
[No Abstract] [Full Text] [Related]
30. Nanotherapeutics relieve rheumatoid arthritis.
Yang M; Feng X; Ding J; Chang F; Chen X
J Control Release; 2017 Apr; 252():108-124. PubMed ID: 28257989
[TBL] [Abstract][Full Text] [Related]
31. Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy.
Medina-Reyes EI; Garcia-Viacobo D; Carrero-Martinez FA; Chirino YI
Crit Rev Ther Drug Carrier Syst; 2017; 34(1):35-61. PubMed ID: 28322140
[TBL] [Abstract][Full Text] [Related]
32. Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.
Seleci M; Ag Seleci D; Scheper T; Stahl F
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671589
[TBL] [Abstract][Full Text] [Related]
33. Neodymium doped hydroxyapatite theranostic nanoplatforms for colon specific drug delivery applications.
Victor SP; Paul W; Vineeth VM; Komeri R; Jayabalan M; Sharma CP
Colloids Surf B Biointerfaces; 2016 Sep; 145():539-547. PubMed ID: 27281239
[TBL] [Abstract][Full Text] [Related]
34. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
Patra CR
Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
[No Abstract] [Full Text] [Related]
35. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
36. Nanomedicine and personalised medicine: understanding the personalisation of health care in the molecular era.
Noury M; López J
Sociol Health Illn; 2017 May; 39(4):547-565. PubMed ID: 27782304
[TBL] [Abstract][Full Text] [Related]
37. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
[TBL] [Abstract][Full Text] [Related]
38. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Wang Z; Wu H; Liu P; Zeng F; Wu S
Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
[TBL] [Abstract][Full Text] [Related]
39. Plasmonic/Magnetic Multifunctional nanoplatform for Cancer Theranostics.
Ravichandran M; Oza G; Velumani S; Ramirez JT; Garcia-Sierra F; Andrade NB; Vera A; Leija L; Garza-Navarro MA
Sci Rep; 2016 Oct; 6():34874. PubMed ID: 27721391
[TBL] [Abstract][Full Text] [Related]
40. Targeted, triggered drug delivery to tumor and biofilm microenvironments.
Benoit DS; Koo H
Nanomedicine (Lond); 2016 Apr; 11(8):873-9. PubMed ID: 26987892
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
